Skip to main content

68th Annual Scientific Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Red Recording

Sig Meeting

16 Views

Therapeutics (Industry)

(T 94) Efficacy and safety of zavegepant for the acute treatment of migraine: pooled analysis of two phase 3 randomized controlled trials

Non-presenting Author(s)

Amaal J. J. Starling, MD

Associate Professor of Neurology
Mayo Clinic Arizona
Scottsdale, Arizona, United States
SY

Shengyuan Yu, n/a

Director
Chinese PLA General Hospital, Beijing, China
Beijing, Beijing, United States
LM

Linda Mosher, n/a

Pfizer, Groton, CT, USA
Groton, Connecticut, United States

Presenting Author(s)

Robert J. Fountaine, n/a

Global Clinical Lead - CGRP Migraine Franchise
Pfizer Inc., New York, NY, USA
Groton, Connecticut, United States

Non-presenting Author(s)

JY

Jerry Yang, n/a

Pfizer, New York, NY, USA
New York, New York, United States
PW

Panpan Wang, n/a

Pfizer R&D, Shanghai, China, United States
JW

Jing Wang, n/a

Pfizer R&D, Beijing, China, United States
SS

Samantha Sweeney, n/a

Pfizer, New York, NY, USA
Carlsbad, California, United States